Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 10/20 | 0.70 |
| ▸ | CES1 | P23141 | 10/20 | 0.70 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ASPH | Q12797 | 1/20 | 0.33 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760850 | 0.82 | CES2 (0.73) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL241797 | 0.80 | CES2 (0.70) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL7744985 | 0.80 | CES2 (0.70) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL5301076 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL1003016 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL30954397 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL671906 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1HPGD | |
| SCHEMBL7445318 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 | |
| Hydrochloric Acid SCHEMBL4730575 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 | |
| SCHEMBL6718922 | 0.78 | CES2 (0.67) | CES2CES1BCHEALDH1A1MAP2K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629494-B2 | Process for producing cyclopropylphenol derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20090054681-A1 | Production Process of cyclopropylphenol derivatives | SANKYO AGRO COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1880987-A1 | PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE | Sankyo Agro Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054681-A1 | Production Process of cyclopropylphenol derivatives | CBR3, CYP4X1, CYP4A11 | CES2 993/4885CES1 2320/4885BCHE 4242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.